216 related articles for article (PubMed ID: 20329730)
1. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors.
Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH
J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730
[TBL] [Abstract][Full Text] [Related]
2. Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives.
Qian K; Nakagawa-Goto K; Yu D; Morris-Natschke SL; Nitz TJ; Kilgore N; Allaway GP; Lee KH
Bioorg Med Chem Lett; 2007 Dec; 17(23):6553-7. PubMed ID: 17935987
[TBL] [Abstract][Full Text] [Related]
3. Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.
Yu D; Sakurai Y; Chen CH; Chang FR; Huang L; Kashiwada Y; Lee KH
J Med Chem; 2006 Sep; 49(18):5462-9. PubMed ID: 16942019
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.
Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH
Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives.
Kashiwada Y; Chiyo J; Ikeshiro Y; Nagao T; Okabe H; Cosentino LM; Fowke K; Morris-Natschke SL; Lee KH
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1387-90. PubMed ID: 10993248
[TBL] [Abstract][Full Text] [Related]
6. Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.
Qian K; Bori ID; Chen CH; Huang L; Lee KH
J Med Chem; 2012 Sep; 55(18):8128-36. PubMed ID: 22978745
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.
Huang L; Ho P; Lee KH; Chen CH
Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103
[TBL] [Abstract][Full Text] [Related]
8. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.
Qian K; Yu D; Chen CH; Huang L; Morris-Natschke SL; Nitz TJ; Salzwedel K; Reddick M; Allaway GP; Lee KH
J Med Chem; 2009 May; 52(10):3248-58. PubMed ID: 19388685
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants.
Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH
Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973
[TBL] [Abstract][Full Text] [Related]
10. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
Baglin I; Mitaine-Offer AC; Nour M; Tan K; Cavé C; Lacaille-Dubois MA
Mini Rev Med Chem; 2003 Sep; 3(6):525-39. PubMed ID: 12871156
[TBL] [Abstract][Full Text] [Related]
11. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.
Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A
Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960
[TBL] [Abstract][Full Text] [Related]
12. Discovery and synthesis of novel beesioside I derivatives with potent anti-HIV activity.
Wu H; Ma G; Yang Q; Zhu Y; Huang L; Tian Y; Yang X; Zhang M; Chen CH; Morris-Natschke SL; Yang M; Xu X; Lee KH
Eur J Med Chem; 2019 Mar; 166():159-166. PubMed ID: 30703659
[TBL] [Abstract][Full Text] [Related]
13. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L
J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990
[TBL] [Abstract][Full Text] [Related]
14. Structure and Anti-HIV Activity of Betulinic Acid Analogues.
Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X
Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.
Zhao Y; Chen CH; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2021 Apr; 215():113287. PubMed ID: 33639343
[TBL] [Abstract][Full Text] [Related]
16. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
[TBL] [Abstract][Full Text] [Related]
17. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH
J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid derivatives as HIV-1 antivirals.
Aiken C; Chen CH
Trends Mol Med; 2005 Jan; 11(1):31-6. PubMed ID: 15649820
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of betulin derivatives with AZT as potent anti-HIV agents.
Xiong J; Kashiwada Y; Chen CH; Qian K; Morris-Natschke SL; Lee KH; Takaishi Y
Bioorg Med Chem; 2010 Sep; 18(17):6451-69. PubMed ID: 20673723
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.
Huang L; Yuan X; Aiken C; Chen CH
Antimicrob Agents Chemother; 2004 Feb; 48(2):663-5. PubMed ID: 14742233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
